Definitive Contract W81XWH17C0159
Award Date 9/25/17
Potential Completion Date 9/30/21
Potential Value $973K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Winston-Salem, NC 27101, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a $998,790.43 federal contract award from the U.S. Army Medical Command (MEDCOM) to Keranetics, LLC, a small business. The contract is a Small Business Innovation Research (SBIR) Phase II award, which typically funds further development of technologies previously explored in a Phase I effort. The contract is a definitive contract with a completion date of November 5, 2019. The contract was set aside for small businesses. No additional details about the specific product or service being...
- This is a $999,998.87 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Keranetics, LLC, a for-profit limited liability company. The contract was awarded on September 1, 2015 and has an ultimate completion date of January 31, 2021. The award is for the DHP SIBR SECOND PHASE II effort under SBIR Topic #OSD10-H03. The contract is a definitive contract with a cost-no-fee pricing type. Keranetics has prior experience as a federal grant prime...
- This is a $3,111,212 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Kericure Inc., a woman-owned small business, for the clinical validation of a portable, ruggedized antimicrobial wound dressing for the management of large surface area burns in prolonged field care and long-term care settings. The contract is part of the Small Business Innovation Research (SBIR) Program's Phase III, which focuses on the demonstration and delivery of technologies that have...
- The Defense Health Agency awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Kericure Inc., a women-owned small business specializing in advanced wound care products, on September 22, 2023. The contract, designated as a Total Small Business set-aside, supports the development of deployable wound care products designed to mitigate infection and decrease preventable deaths on the battlefield and in long-term care settings. Work will be performed at Kericure's...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Applied Tissue Technologies LLC, a for-profit limited liability company. The contract, valued at $420,308.75, is for the "Development of Technologies that Address the Complex Architecture of the Face during the Treatment of Severe Facial Burn Injury". This SBIR Phase II contract was awarded under the Major Program Code S10. The contract is a Definitive Contract with a...
- <p>This is a firm fixed-price contract awarded by the U.S. Army Medical Command (MEDCOM) to Nanoderm Sciences, Inc., a small business, for a SBIR (Small Business Innovation Research) Phase I project. The contract has a ceiling value of $149,837.83 and a completion date of April 27, 2016. The contract is for research and development under the SBIR program, but the specific details of the products or services being delivered are not provided in the information given.</p>
- The U.S. Department of Defense's Defense Health Agency awarded a $1,986,378 Definitive Contract to Synedgen, Inc., a small business prime contractor, to conduct Phase II Small Business Innovation Research (SBIR) efforts for the development of technologies to control scar formation after burn injuries. The contract is designated as a Total Small Business set-aside and has an ultimate completion date of April 1, 2023. Synedgen, a for-profit manufacturer with expertise in regenerative medicine...
- The Department of the Army Medical Command awarded a $549,725 firm fixed price Small Business Innovation Research Program Phase III follow-on medical research and development contract to Synedgen, Inc. for the development of technologies that control scar formation after burn injuries. As the prime contractor, Synedgen will leverage its expertise in regenerative medicine and wound healing to advance scientific knowledge and technologies aimed at reducing scarring and improving outcomes for...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Kerberos International, Inc., a self-certified small disadvantaged and women-owned small business. The $972,654.73 firm fixed-price contract will support Kerberos' STTR Phase II research and development efforts. Kerberos has extensive experience providing protective security officer services to federal agencies like the Department of Homeland...
- This is a $149,035.04 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Premitec Inc., a for-profit organization. The contract was awarded on November 26, 2013, with an ultimate completion date of October 5, 2015. It is a firm-fixed-price definitive contract, which means the agreed-upon price for the contracted work will not change. The SBIR program is designed to support research and development of innovative technologies by small...
This is a $973,434.89 definitive contract awarded by the Department of the Army Medical Command to Keranetics Inc., a small business, under the SBIR Program Phase II. The contract is for the development of technology to address the complex architecture of the face during the treatment of severe facial burn injury. Keranetics, a for-profit organization that provides medical research and development services, will perform the work in Winston-Salem, North Carolina. This award is related to the agency's medical countermeasure programs and Keranetics' prior work supporting animal studies and research on keratin-based technologies for stabilizing composite tissue injuries.
Generated 3/23/24, 5:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Funding Only Action | $24.7k | 3/28/22 | |
| P00004 | Vendor DUNS or Name Change - Non-Novation | $0 | 11/12/21 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 9/30/20 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 7/19/19 | |
| P00001 | Novation Agreement | $0 | 1/17/19 |